EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gender difference in pre-clinical liver-directed gene therapy with lentiviral vectors

Efrain Guzman, Cheen Khoo, Deirdre O'Connor, Gayathri Devarajan, Sharifah Iqball, Bernard Souberbielle, Kyriacos Mitrophanous, Yatish Lad

Experimental Biology and Medicine · 2025

DOI: 10.3389/ebm.2025.10422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Efrain Guzman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Biomedica (UK) Limited, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Lentivirus, Genetic Vectors, Genetic Therapy, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral vector-based therapies are effective therapeutics for the correction of several disorders, both in mouse models and in humans. Several pre-clinical studies have demonstrated differences in transduction efficiencies and therapeutic effect between male and female mice dosed with AAV-based gene therapy product candidates. Here, we report gender-specific transduction and transgene expression differences in mice dosed systemically with lentiviral vectors (LVV). Male mice systemically dosed with LVV carrying the reporter gene luciferase showed at least a 12-fold higher expression of luciferase and a higher vector copy number (VCN) in their livers compared with female mice. Lastly, PAH Enu2 male mice dosed with a LVV carrying the human phenylalanine hydroxylase (PAH) transgene were observed to have a higher VCN than their female littermates. These findings suggest that sex-based differences initially observed in AAV-mediated therapies also apply to LVV, but the exact mechanism remains to be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LentivirusGenetic VectorsGenetic TherapyLiverAnimalsFemaleMaleMiceHumansSex FactorsTransduction, GeneticMice, Inbred C57BLTransgenesLuciferases

Stichwörter der Autor:innen

AAVPAHadeno-associated virusgenderlentiviral vectorslivermurine

Substanzen

Luciferases

Autor:innen und Institutionen

  • Oxford Biomedica (UK) Limited, Oxford, United Kingdom.

Zitieren

APA

Guzman, E., Khoo, C., O'Connor, D., Devarajan, G., Iqball, S., Souberbielle, B., Mitrophanous, K., & Lad, Y. (2025). Gender difference in pre-clinical liver-directed gene therapy with lentiviral vectors. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10422

Vancouver

Guzman E, Khoo C, O'Connor D, Devarajan G, Iqball S, Souberbielle B, et al. Gender difference in pre-clinical liver-directed gene therapy with lentiviral vectors. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10422

BibTeX
@article{Guzman2025,
  author = {Guzman, Efrain and Khoo, Cheen and O'Connor, Deirdre and Devarajan, Gayathri and Iqball, Sharifah and Souberbielle, Bernard and Mitrophanous, Kyriacos and Lad, Yatish},
  title = {Gender difference in pre-clinical liver-directed gene therapy with lentiviral vectors},
  journal = {Experimental Biology and Medicine},
  year = {2025},
  doi = {10.3389/ebm.2025.10422}
}
Kostenlos starten →